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A screen for antifungal compounds from Lysobacter enzymogenes strain C3, a bacterial biological control agent of
fungal diseases, has previously led to the isolation of heat-stable antifungal factor (HSAF). HSAF exhibits inhibitory
activities against a wide range of fungal species and shows a novel mode of antifungal action by disrupting the
biosynthesis of a distinct group of sphingolipids. We have now determined the chemical structure of HSAF, which
is identical to that of dihydromaltophilin, an antifungal metabolite with a unique macrocyclic lactam system
containing a tetramic acid moiety and a 5,5,6-tricyclic skeleton. We have also identified the genetic locus responsible
for the biosynthesis of HSAF in strain C3. DNA sequencing of this locus revealed genes for a hybrid polyketide
synthase-nonribosomal peptide synthetase (PKS-NRPS), a sterol desaturase, a ferredoxin reductase, and an argi-
nase. The disruption of the PKS-NRPS gene generated C3 mutants that lost the ability to produce HSAF and to
inhibit fungal growth, demonstrating a hybrid PKS-NRPS that catalyzed the biosynthesis of the unique macrolac-
tam system that is found in many biologically active natural products isolated from marine organisms. In addition,
we have generated mutants with disrupted sterol desaturase, ferredoxin reductase, and arginase and examined the
metabolites produced in these mutants. The work represents the first study of the genetic basis for the biosynthesis
of the tetramic acid-containing macrolactams. The elucidation of the chemical structure of HSAF and the identi-
fication of the genetic locus for its biosynthesis establish the foundation for future exploitation of this group of
compounds as new fungicides or antifungal drugs.
Heat-stable antifungal factor (HSAF) is a secondary metab-
olite produced by the bacterium Lysobacter enzymogenes strain
C3 (originally called Stenotrophomonas maltophilia strain C3
[24]), a biological control agent originally isolated from grass
foliage (7). Strain C3 was demonstrated in the field to reduce
diseases caused by multiple fungal pathogens, including Bipo-
laris sorokiniana (28), Fusarium graminearum (26), Rhizoctonia
solani (7), and Uromyces appendiculatus (27). It was also found
to be effective in inhibiting the soilborne pathogens Pythium
ultimum (12) and Magnaporthe poae (13) in greenhouse exper-
iments. A search for antifungal factors in strain C3 led to the
isolation of HSAF, which exhibits strong activity against a wide
range of fungi (15).
The mechanism by which HSAF inhibits the growth of
Aspergillus nidulans has been studied (16). HSAF disrupts the
polarized growth of the fungus. Genetic analysis of A. nidulans
mutants suggests that HSAF targets the biosynthesis of sphin-
golipids (16), which are ubiquitous components of eukaryotic
cell membranes and signaling molecules involved in numerous
cellular processes. Interestingly, HSAF appears to target a
distinct group of sphingolipids that are required for polarized
growth of filamentous fungi and appears to be absent from
mammals and plants. Therefore, the antifungal mechanism of
HSAF represents an unprecedented mode of action for an
antifungal metabolite, and thus, the study of HSAF could lead
to the development of novel fungicides or antifungal drugs.
The objectives of this study were to determine the chemical
structure of HSAF and to identify the genetic locus in strain C3
that is required for the production of HSAF. The outcomes of
the study will provide important knowledge for future appli-
cation of HSAF and possible genetic engineering of the bio-
synthetic pathway to improve the production of HSAF or to
produce new analogs.
MATERIALS AND METHODS
Bacterial and fungal strains, plasmids, and general DNA manipulations. L.
enzymogenes strain C3 and other bacterial strains were grown in Luria-Bertani
(LB) broth medium or 1/10-strength tryptic soy broth (1/10 TSB; Sigma) at 28°C
with shaking. Escherichia coli strain DH5 was used as the host for general DNA
propagations. E. coli S17-1 was obtained from D. Y. Kobayashi (Rutgers Uni-
versity, New Brunswick, NJ). The plasmids used for cloning and sequencing
included the pGEM-zf series from Promega (Madison, WI) and pANT841 (21).
Plasmid preparation and DNA gel extraction were carried out with commercial
kits (QIAGEN, Valencia, CA), and all other manipulations were performed by
standard methods (22). The genomic DNA of L. enzymogenes strain C3 was
prepared as described previously (12).
Cloning of genes for HSAF biosynthesis. Genomic DNA was prepared from a
polyketide synthase (PKS)-disrupted C3 mutant (see below). Approximately 10 g
of the DNA was digested with 50 units of PstI in a total volume of 50 l. The
PstI-digested DNA was precipitated by ethanol and resuspended in 20 l H2O. The
ligation reaction was performed by mixing 8 l of the digested DNA with 1 l of
ligation buffer and 1 l of T4 DNA ligase (5 units; Promega), and the mixture was
incubated at 15°C for 24 h. An aliquot of 5 l of the ligation mixture was used to
transform E. coli DH5, and the cells were spread onto LB plates containing 20
g/ml gentamicin. Plasmid DNA was prepared from the developed colonies and
screened by PCR assays with primers P1 and P2 (see below and Fig. 2). One of the
rescued plasmids, pJQ200SK-5.3KB, which harbors a 5.3-kb DNA fragment, was
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sequenced. Similarly, the genomic DNA was digested with BamHI, SalI, or SacI; and
individual plasmids were rescued upon self-ligation. The sequencing of these plas-
mids revealed an approximately 13.5-kb DNA region.
Construction of gene disruption vectors. To construct the PKS disruption
vector, two PCR primers, primers P1 (CCGCGGAAGTCGAAGCAGTA) and
P2 (AAGGACTGCCTCACCGACAC), were designed on the basis of the pre-
liminary data reported in Folman’s Ph.D. dissertation (6). Folman obtained an
818-bp DNA fragment from a minitransposon (mini-Tn5 Cm) mutant of L.
enzymogenes strain 3.1T8. The transposon insertion led to the loss of antifungal
activity of strain 3.1T8. On the basis of this information, a 407-bp fragment was
amplified by PCR from the genomic DNA of strain C3. The fragment was cloned
into T vector (Promega) to confirm its identity by DNA sequencing and was then
transferred to conjugation vector pJQ200SK (20) as an ApaI/SacI fragment to
produce pJQ200SK-PKS (see Fig. 2). To construct the nonribosomal peptide
synthetase (NRPS) module disruption vector, a 482-bp fragment was amplified
from genomic DNA of strain C3 by PCR with primer NRPS1-F (GTTGAGCT
GCTTGAGGAACC) and primer NRPS1-R (GATCTTCATGGCTTGGTACT
CC). This fragment was cloned into the pGEM-T vector. The PCR product was
released from the T vector by ApaI and SacI digestions and cloned into the same
sites of pJQ200SK to produce pJQ200SK-NRPS. To disrupt the ferredoxin
reductase (FNR) gene, a 373-bp internal fragment from the predicted gene (the
Ferr fragment) was released by BamHI and SacI digestion from a subclone,
pGEM3zf-3.0Kb. This fragment was cloned into the same sites of pJQ200SK to
produce gene disruption construct pJQ200SK-Ferr. To disrupt the sterol desatu-
rase gene, a 797-bp internal fragment from the putative gene (the SD fragment)
was released by EagI digestion from a subclone, pGEM3zf-3.0Kb. This fragment
was cloned into the NotI site of pANT841 to produce pANT-SD. The sterol
desaturase fragment was released by SpeI and XhoI digestions and was cloned
into the same sites of pJQ200SK to produce the sterol desaturase gene disruption
construct pJQ200SK-SD. To disrupt the arginase gene, a 396-bp internal frag-
ment from the predicted gene (the ARG fragment) was released by ApaI diges-
tion from a subclone, pGEM3zf-2.3k. This fragment was cloned to the same site
on pJQ200SK to produce the arginase disruption construct pJQ200SK-ARG.
Conjugal transfer of pJQ200SK constructs from E. coli S17-1 to L. enzymo-
genes strain C3. pJQ200SK constructs were first introduced into E. coli S17-1 and
then conjugally transferred from strain S17-1 to strain C3. To conjugally transfer
the construct, a single colony of the S17-1 transformant was incubated in liquid
LB medium supplemented with 20 g/ml gentamicin at 37°C overnight. Strain C3
was also grown in liquid LB medium supplemented with 25 g/ml kanamycin at
28°C for 48 h. Before conjugation, a fresh culture was initiated from each of the
two seed cultures in liquid LB and incubated until the cell density reached an
optical density at 595 nm of 0.7. A 1-ml aliquot of the cell suspension was taken
from each culture, and the cells were collected by centrifugation at 3,000  g for
3 min. The cells were suspended in 0.5 ml of 10 mM MgSO4, and the two cell
suspensions were mixed. The mixture was spread onto five LB plates, and the
plates were incubated at 28°C for 4 h. The cells were washed off the plates with
20 ml of 10 mM MgSO4, and 0.5 ml of the cells washed off of the plates was
spread onto LB plates supplemented with 20 g/ml kanamycin and gentamicin.
The plates were incubated at 28°C for 2 days for selection. The colonies that
developed on the selection medium were candidates of C3 gene disruption
mutants.
Screening for gene disruption mutants. To screen the gene-disrupted C3
mutants, genomic DNA was prepared from LB cultures of the individual candi-
dates. For the PKS-disrupted mutants, primer P3 (GGTGTCGATCGACAG
GCT) and primer P4 (AGCGACTACCGCGCGTTC), as well as universal
primer T3 and primer T7 on vector pJQ200SK-PKS, were used for PCR. Primers
P3 and P4 anneal to the flanking regions of the 407-bp fragment used in the
homologous recombination (see Fig. 2). Thus, only the mutants that result from
a homologous recombination produce a 453-bp PCR fragment when primers P3
and T3 are used and a 522-bp fragment when primers T7 and P4 are used. The
FIG. 1. Structures of HSAF and several tetramic acid-containing
macrolactams.
FIG. 2. Scheme for PKS gene disruption in L. enzymogenes strain C3. A 407-bp fragment of the gene (shaded bar) was amplified from the
genomic DNA and cloned into a gene disruption vector to produce pJQ200SK-PKS. PCR primers (primers P1, P2, P3, P4, T3, and T7) and their
relative positions are shown as small arrows. B, BamHI; E, EcoRI; K, KpnI; P, PstI; S, SacI; Gmr, gentamicin resistance gene.
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wild type or mutants that resulted from random insertion did not produce any of
the PCR fragments. To identify the NPRS-disrupted mutants, PCR was carried
out with primer N1 (ACGCCAAGCTCGAAATTAAC) and primer N2 (ATC
GAGCATTACCGCAACAG). The expected size of the PCR product is 695 bp,
and this product produces two fragments of 225 bp and 470 bp upon SphI
digestion. To identify the ferredoxin reductase gene-disrupted mutants, PCR was
carried out with primer Ferr-1 (ACGACAGCCTTTTCAGCTTC) and primer
T7. The expected size of the PCR product is 661 bp, and this product produces
two fragments of 209 bp and 452 bp upon SacI digestion and two fragments of
272 bp and 389 bp upon SmaI digestion. To identify the sterol desaturase
gene-disrupted mutants, PCR was performed with primer T7 and primer S5
(TGAACGGATTATCAGAGCAC). The expected product is a 957-bp fragment
that produces three fragments of 670 bp, 171 bp, and 116 bp upon SphI digestion.
To identify the arginase gene-disrupted mutants, PCR was conducted with
primer T7 and primer Arg1 (GTTCGCATCCACCTCTTTTTC). The expected
size is 606 bp, and this product produces two fragments of 294 bp and 312 bp
upon SalI digestion.
Isolation and HPLC analysis of metabolites from strain C3 and mutants.
Strain C3 and individual mutant strains were cultured in 1/10 TSB (supple-
mented with 20 g/ml gentamicin for mutant strains) at 28°C in a rotary shaker
at 180 rpm for 4 days. The supernatant was collected from each culture by
centrifugation at 10,000  g at 4°C for 30 min. To analyze the metabolites
excreted into the culture, the supernatant (10 to 20 l) was directly injected into
a high-pressure liquid chromatograph. A high-pressure liquid chromatography
(HPLC) system (ProStar, model 210; Varian, Walnut Creek, CA) with an
Alltima C18LL column (250 mm by 4.6 mm [inner diameter]; 5 m; Alltech,
Deerfield, IL). The mobile phases were water-trifluoroacetic acid (TFA; 100:
0.025; vol/vol) (mobile phase A) and acetonitrile-TFA (100:0.025; vol/vol) (mo-
bile phase B) with a gradient of 0 to 40% mobile phase B in mobile phase A in
the first 10 min, 40 to 80% mobile phase B in mobile phase A from 10 to 15 min,
80% mobile phase B in mobile phase A from 15 to 20 min, 80 to 100% mobile
phase B in mobile phase A from 20 to 21 min, 100% mobile phase B in mobile
phase A from 21 to 23 min, and 100 to 0% mobile phase B in mobile phase A
from 23 to 25 min. The flow rate was 1.0 ml/min. The peaks were detected at 220
nm on a UV-visible detector (ProStar, model 310; Varian). To prepare HSAF
and its analogs for structural analysis, ammonium sulfate was added to the
supernatant of the culture, with constant stirring until the final concentration
reached 0.5 g/ml. The solution was incubated at 4°C for 12 h. The precipitate was
collected by centrifugation at 10,000  g at 4°C for 25 min and was dissolved in
100% methanol. The methanol fraction containing HSAF or its analogs was
centrifuged at 10,000  g at 25°C for 10 min, and the resultant supernatant was
collected and dried with a Rotavapor. The residues were redissolved in 10%
acetonitrile, and the solution was loaded on a Sep-Pak Vac 35-ml (10-g) C18
cartridge (Waters, Milford, MA) previously conditioned with 200 ml of 100%
acetonitrile, followed by 200 ml of 10% acetonitrile. The cartridge was sequen-
tially washed with 100 ml of 10% acetonitrile and 100 ml of 20% acetonitrile, and
HSAF was eluted with 100 ml of 30% acetonitrile. HSAF was further purified by
preparative HPLC (250 mm by 10 mm [inner diameter]; 5-m) column with the
same system described above. The fractions containing HSAF were combined,
and the final pure HSAF was obtained by crystallization in methanol.
HR-MS and NMR analysis of the metabolites. The melting point was mea-
sured with a Thomas-Hoover capillary melting point apparatus and was uncor-
rected. High-resolution electron-spray ionization mass spectrometry (MS) of the
purified HSAF was performed on an API Qtrap 4000 instrument. The samples
were directly infused in the mass spectrometer and were analyzed in the positive
ion mode by using a Turbo ion spray source. The nuclear magnetic resonance
(NMR) spectra (1H NMR and 1H-1H correlation spectroscopy, obtained by
using a standard pulse program) were recorded on a Varian Mercury-400BB
instrument in CD3OD and were calibrated by using the solvent peak (H 3.31) as
an internal reference.
Biological assays for antifungal activity. One milliliter of the culture broth of
the mutants or the wild type was collected and centrifuged on a bench-top
centrifuge at 16,000  g for 10 min. The supernatant was transferred to a new
tube and was boiled for 10 min in a water bath. The sample was centrifuged at
FIG. 3. Screening of the PKS gene-disrupted mutants by PCR assays. Genomic DNA was prepared from the gentamicin-resistant colonies and used
as the template for PCR with primers P4 and T7 (Fig. 2). The expected size of the PCR product from homologous recombinants is 522 bp. Lane 1, control
reaction without template; lane 2, wild type; middle unnumbered lanes, gentamicin (Gm)-resistant colonies; lane 4, 100-bp DNA ladder.
FIG. 4. HPLC analysis and antifungal activity assay for the PKS-dis-
rupted mutants. (A and B) HPLC traces of culture broths from mutant
strain K19 (A) and wild type (B), with the peak of HSAF indicated; (C
and D) activity assay for the culture broth from mutant strain K19 (C) and
the wild type (D) by using Bipolaris sorokiniana as the test organism.
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16,000  g for 10 min, and the supernatant was transferred to another tube and
used for biological assays. The slide glass method was used for the assay (16). On
a slide glass, 1 l of spores (105/ml) of B. sorokiniana, Fusarium graminearum, or
Fusarium verticillioides was mixed with 9 l of culture broth. The slide glass was
put inside a 15-mm petri dish with two pieces of wet Whatman paper at the
bottom and was incubated at 25°C for 12 h. The inhibitory effect of the culture
broth on spore germination was observed under a microscope. In control exper-
iments, 1 l of the spores was mixed with 9 l of culture medium (also supple-
mented with 20 g/ml of gentamicin in the cases of the controls for the mutants)
and was incubated similarly. For the bioassays of purified HSAF and its analogs,
the preparations were dried in a Speed-Vac and redissolved in 100% methanol.
The methanol solution was first applied onto a slide glass and air dried. One
microliter of B. sorokiniana spores and 9 l of culture medium were then added
directly to the spot. In control experiments, methanol was applied to the slide
and similarly air dried.
RESULTS
Chemical structure of HSAF. Strain C3 produced no detect-
able HSAF in rich media, such as LB or full-strength TSB.
However, the strain produced HSAF in nutritionally limited
media, such as 10% TSB. Following extraction with ammo-
nium sulfate and methanol (16), we could obtain approxi-
mately 30 to 60 g HSAF from 1 ml culture. Purified HSAF
exhibited potent inhibitory activities against many fungal
pathogens. At a concentration of 0.3 to 1.5 M, HSAF ar-
rested spore germination in B. sorokiniana and caused reduced
hyphal extension or profuse branching of F. graminearum and
F. verticillioides (data not shown).
The purified HSAF was analyzed by mass spectrometry and
one- and two-dimensional NMR. High-resolution electron-
spray ionization mass spectrometry gave an m/z 513.2954 for
[M(C29H40O6N2)  H]
 (calculated, 513.2959), which is 2
mass units heavier than the mass of the reference compound,
maltophilin (purchased from EMC Microcollections GmbH,
Tubingen, Germany) (Fig. 1). HSAF appeared as a colorless
powder with a melting point of greater than 300°C when it was
crystallized from methanol. 1H-NMR (in CD3OD) gave the
following data:  8.02 (1H, br s, OH or NH, disappeared
immediately after the addition of D2O or after the sample was
kept standing for 2 days), 7.13 (1H, d, J  13.2 Hz, H-10), 6.65
(1H, br dd, H-11), 6.05 (1H, br t, J  10.0 Hz, H-25), 5.80 (1H,
br d, J  12.0 Hz, H-26), 3.97 (1H, br d, J  6.0 Hz, H-4), 3.92
(1H, br s, H-5), 3.48 (2H, m, H-2a,24a), 3.36 (1H, m, H-14),
2.79 (1H, br t, J  12.4 Hz, H-2b), 2.45 (1H, m, H-20), 2.08 to
2.19 (4H, m, H-12, 19a, 21a, 24b), 1.86 to 1.92 (2H, m, H-13a,
16), 1.72 (1H, m, H-22), 1.63 (2H, m, H-3a, 30a), 1.29 to 1.36
(5H, m, H-3b, 13b, 17, 18, 23), 1.23 (1H, q, J  10.0 Hz H-15),
1.11 (3H, d, J  6.4 Hz, H-29), 1.10 (1H, overlapping, H-30b),
0.96 (1H, m, H-21b), 0.90 (3H, t, J  7.4 Hz, H-31), 0.86 (1H,
overlapping, H-19b). These assignments, which were based on
the results of the 1H-1H correlation spectroscopy experiment,
are consistent with the reported values for dihydromaltophilin
recorded in CD3OD-CDCl3 (3:1) (8). The coupling constants,
which were well resolved for individual protons, are presented
here, since the previous paper did not report these values.
These data show that HSAF isolated from L. enzymogenes
strain C3 has a chemical structure identical to that of dihydro-
maltophilin (Fig. 1), which was isolated from a Streptomyces
species (8).
PKS-disrupted mutants lost the ability to produce HSAF
and to inhibit fungal growth. In order to identify the genetic
locus required for the biosynthesis of HSAF in strain C3, we
FIG. 5. Partial map of the 13.5-kb region of L. enzymogenes strain C3 hosting the HSAF biosynthetic genes. The predicted functions of the open
reading frames are indicated. Restriction enzyme sites: A, ApaI; B, BamHI; E, EcoRI; K, KpnI; S, SacI. Domains of the hybrid PKS-NRPS: KS,
ketosynthase; AT, acyltransferase; DH, dehydratase; KR, ketoreductase; ACP, acyl carrier protein; C, condensation; A, adenylation; PCP, peptidyl
carrier protein; TE, thioesterase. The highly conserved signature motifs within the domains are shown, with the active-site residues highlighted in
boldface letters. MxaD, PKS from Stigmatella aurantiaca (GenBank accession number AAK57188); MxaE, PKS from S. aurantiaca (GenBank
accession number AAK57189); HSAF, the PKS-NRPS from L. enzymogenes C3; GenBank accession number YP_529192, PKS-NRPS sequence
from Saccharophagus degradans 2-40 (GenBank accession number YP_529192).
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generated mutants through target-specific gene disruption by
taking advantage of the partial sequence for a putative PKS
gene isolated from L. enzymogenes strain 3.1T8 (6). Using two
primers based on a region in the reported sequence, we am-
plified a 407-bp PCR product from the genomic DNA of strain
C3. The DNA sequence of the fragment from strain C3 was
96.6% identical to that from strain 3.1T8. It also suggested that
the 818-bp sequence reported in the earlier study likely con-
tained sequence errors that resulted in frame shifts.
To determine if the putative PKS gene is involved in HSAF
biosynthesis, we constructed a gene disruption vector, pJQ200SK-
PKS, using the fragment amplified by PCR. Homologous recom-
bination of the fragment with the corresponding region in the
chromosome of C3 should generate PKS-disrupted mutants
(Fig. 2). After mating of E. coli S17-1 carrying pJQ200SK-PKS
with strain C3, 22 colonies developed on selection medium
containing gentamicin and kanamycin. Among the colonies, 12
resulted from homologous recombination, as confirmed by
PCR analysis. A 522-bp fragment was amplified from the
genomic DNA prepared from the individual colonies by using
primer T7 and primer P4 (Fig. 3), whereas a 453-bp fragment
was obtained when primers P3 and T3 were used (data not
shown). No PCR product was obtained from the wild type or
the remaining 10 colonies, which presumably resulted from
random insertion of the vector. The PCR products were se-
quenced, and the result confirmed that the colonies were PKS-
disrupted mutants (Fig. 2).
The PKS-disrupted mutants were examined for their
antifungal activities and HSAF production. While the boiled
culture broth of wild-type strain C3 completely inhibited
spore germination in B. sorokiniana, the boiled culture broth of
the PKS-disrupted mutants did not inhibit spore germination
(Fig. 4). The supernatants from the mutant and the wild-type
cultures were further analyzed by HPLC. The supernatant
from the wild type exhibited a peak at 19.2 min that corre-
sponded to HSAF, whereas the mutants did not produce
HSAF (Fig. 4). The results demonstrate that the putative PKS
gene is required for the biosynthesis of HSAF.
HSAF biosynthetic genes. Following digestion of genomic
DNA from the PKS-disrupted mutants with several restriction
enzymes and rescue of the vector pJQ200SK by self-ligation,
we sequenced the regions flanking the inserted vector. Se-
quences totaling about 13.5 kb were determined, and the
analysis of the sequences indicated that this region contains
four open reading frames: those for a hybrid polyketide
synthase-nonribosomal peptide synthetase, a sterol desatu-
rase, a ferredoxin reductase, and an arginase (Fig. 5). The
hybrid PKS-NRPS contains nine domains: those for ketosyn-
thase, acyltransferase, dehydratase, ketoreductase, acyl carrier
protein, condensation, adenylation, peptidyl carrier protein,
and thioesterase. All the highly conserved signature motifs
within the domains were readily identifiable (Fig. 5). The PKS-
NRPS contains 3,124 amino acid residues and is most similar
(59% identity and 74% similarity from the start to the end) to
the PKS-NRPS sequence from Saccharophagus degradans 2-40
(GenBank accession number YP_529192). The sequence also
showed that the partial sequence of the putative PKS gene
from strain 3.1T8 reported by Folman (6) is located at the
ketosynthase domain of the hybrid PKS-NRPS.
Function of PKS-NRPS gene in HSAF synthesis. To further
confirm the role of the predicted hybrid PKS-NRPS in HSAF
biosynthesis, we generated mutants with a disrupted NRPS
module (at the C-domain region). A total of 32 putative
NRPS-disrupted mutants were produced, 20 of which were
confirmed by PCR assays with primer N1 and primer N2. A
695-bp fragment was amplified from the strains, and the frag-
ment was cleaved by SphI to produce two fragments of 225 bp
and 470 bp, as expected, from the mutants (data not shown).
The PCR product was sequenced to further confirm the iden-
tities of the mutants. HPLC analysis of the culture broth of
four NRPS-disrupted mutants showed that none of the mu-
tants produced HSAF (Fig. 6B). Furthermore, none of the
cultures had activity against B. sorokiniana in the spore germi-
nation assay (data not shown).
Functions of ferredoxin reductase, arginase, and sterol
desaturase genes. Three, 12, and 7 mutant strains with disrup-
tions in the ferredoxin reductase, arginase, and sterol desatu-
rase genes, respectively, were generated by mating of wild-type
C3 with E. coli S17-1 carrying the respective pJQ200SK-gene
construct. Insertion of the vector via homologous recombina-
tion into the target gene was confirmed in these strains by PCR
analysis (data not shown). The mutants were evaluated for
FIG. 6. HPLC analysis of metabolites from mutants with disrupted
gene for the NRPS module, ferredoxin reductase, arginase, and sterol
desaturase. The results for crude extracts from wild-type strain C3 (A),
NRPS-disrupted mutants (B), ferredoxin reductase-disrupted mutants
(C), arginase-disrupted mutants (D) and sterol desaturase-disrupted
mutants (E) are shown.
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antifungal activities by the spore germination assay. Boiled
culture broths from all of the mutant strains had inhibitory
effects on the germination of B. sorokiniana spores similar to
those of the broth from wild-type C3 strain and purified HSAF
(data not shown). HPLC analysis of the broth from cultures of
ferredoxin reductase- and arginase-disrupted mutants indi-
cated that all of the mutants produced HSAF (retention time,
19.2 min), with the yields being similar to that of the wild type
(Fig. 6C and D). This result was confirmed by liquid chroma-
tography-MS, which showed that the compound produced by
the mutants had the same molecular weight as HSAF (data not
shown). Culture broth from the sterol desaturase-disrupted
mutants did not contain HSAF but contained two dramatically
increased metabolites (retention times, 19.9 and 20.4 min, re-
spectively) (Fig. 6E). Activity tests showed that both metabo-
lites were active in antifungal assays (data not shown). These
two metabolites were also present in the mutants of ferredoxin
reductase and arginase, as well as in the wild type, but at a
much lower level. Interestingly, none of the PKS-NRPS-dis-
rupted mutants produced these metabolites (Fig. 4B and Fig.
6B), indicating that these are probably precursors or shunt
products of HSAF.
DISCUSSION
In this study, we identified the primary compound com-
prising the heat-stable antifungal activity in strain C3 to be
dihydromaltophilin, an antibiotic first reported in a Strepto-
myces sp. (8) and an analog of xanthobaccins (17). Dihydro-
maltophilin belongs to a group of tetramic acid-containing
macrolactam natural products, including the marine natural
products cylindramide A (11), discodermide (9), and alter-
amide A (23) (Fig. 1). This group of metabolites has unique
structural features and diverse biological activities, includ-
ing anticancer, antibiotic, antiprotozoal, and antioxidant ac-
tivities; and there has been extensive research interest in
chemical total synthesis to prepare the scarce natural prod-
ucts (2–4, 10, 18). Our study represents the first attempt to
investigate the molecular genetic basis for the biosynthesis
of this group of natural products.
We were successful in identifying the genetic locus for
HSAF biosynthesis in strain C3. The search was facilitated
by the report of a putative PKS gene sequence in strain
3.1T8 (6). The high degree of sequence identity (96%) be-
tween the corresponding PKS gene regions in strains C3 and
3.1T8 and the fact that disruption of the PKS gene function
in both strains resulted in the loss of antifungal activity
suggest that strain 3.1T8 could also produce HSAF.
Whether or not HSAF production is a common trait among
strains of L. enzymogenes, however, is unknown. The ab-
sence of HSAF production in our PKS-NRPS-disrupted mu-
tants demonstrates that the PKS-NRPS gene is required for
the production of HSAF in strain C3. The result also implies
FIG. 7. Proposed biosynthetic pathway for HSAF involving both polyketide and nonribosomal peptide mechanisms. SEnz, the thiol group of
the phosphopantetheinyl cofactor of the carrier proteins (acyl carrier protein or peptidyl carrier protein) within the polyketide synthase or
nonribosomal pepetide synthetase; OH-Orn, -hydroxyornithine. Note that the sequence of the biosynthetic steps illustrated here is just one
of several possibilities.
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that the biosynthesis of HSAF involves a hybrid polyketide-
peptide mechanism.
Since the biosynthetic genes for secondary metabolites in
microorganisms are generally found to cluster together at the
same locus on a chromosome, we first used the PKS fragment
as a probe to screen a genomic library based on the cosmid
pLAFR3 (12) in our initial attempt to obtain the complete
sequence for the PKS gene, as well as other genes required for
HSAF biosynthesis. However, an extensive search of the li-
brary did not produce any positive clones, while the control
experiments with a known ABC transporter as a probe did
successfully identify three positive clones from the same library
(data not shown). Subsequently, we constructed a new genomic
library based on the cosmid SuperCos 1 (Stratagene). Again,
using the PKS fragment as a probe, we isolated four positive
clones from the new library, but none of the cosmid clones was
stable in the host. The insert DNA in the cosmid vector was
found to be either partially lost or rearranged during the re-
generation and subcloning process. These results indicate that
the HSAF biosynthetic genes might be toxic when they are
expressed in the host. Since the direct screening of the genomic
libraries did not lead to the identification of the biosynthetic
genes, we took an alternative approach. We used the genomic
DNA isolated from the gene-disrupted mutants to rescue plas-
mids that contained the homologous region as well as the
flanking regions. The sequencing of the flanking regions even-
tually led to the identification of a gene cluster encoding a
hybrid PKS-NRPS, a sterol desaturase, a ferredoxin reductase,
and an arginase.
The chemical structure of HSAF suggests that an orni-
thine residue is incorporated into the lactam functionalities
and that the biosynthesis of HSAF could involve both
polyketide and nonribosomal peptide mechanisms, as seen
in bleomycins and other natural products (5). This is sup-
ported by the identification of a hybrid PKS-NRPS gene.
Indeed, a disruption of the NRPS module also led to the
elimination of HSAF production in strain C3. This is direct
evidence supporting the notion that the unique structure of
the tetramic acid-containing macrolactam is derived from
hybrid nonribosomal peptide and polyketide biosynthesis. A
FIG. 8. Proposed mechanism for the formation of the two lactam moieties in HSAF. Note that the NRPS may use ornithine as a substrate and
that the -hydroxyl group may be added after the incorporation of the amino acid; alternatively, NRPS may use -hydroxyornithine (OH-Orn)
directly as substrate. SEnz, the thiol group of the phosphopantetheinyl cofactor of the carrier proteins (acyl carrier protein or peptidyl carrier
protein) within the polyketide synthase or nonribosomal pepetide synthetase.
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careful analysis of the adenylation domain of the NRPS
module suggested that this domain is most similar to the
ornithine-activating domain of gramicidin S-synthetase 2
from Brevibacillus brevis (14). Based on this information, we
propose a possible biosynthetic pathway for HSAF (Fig. 7).
Two PKS-synthesized hexaketide chains are condensed with
the NRPS-activated ornithine via Claisen-type condensa-
tions to generate the basic skeleton of this group of natural
products. Following a series of aldol condensations, reduc-
tions, and oxidations, the 5,5,6-membered tricyclic ring sys-
tem is formed and fused to the tetramic acid-containing
macrolactam ring system (Fig. 7). The different patterns of
ring fusion within this group of natural products are intrigu-
ing (Fig. 1). For example, HSAF and discodermide have a
three-ring (5,5,6-membered) system fused to the macrolac-
tam, while ikarugamycin has a different pattern (5,6,5-mem-
bered system [structure not shown]) of the ring system fused
to the macrolactam system. On the other hand, cylindramide
and alteramide A have only a two-ring (5,5-membered) sys-
tem fused to a larger lactam system (Fig. 1). It will be
extremely interesting to exploit the properties of the en-
zymes involved in these post-PKS folding processes. As sug-
gested by this biosynthetic pathway, multiple PKS modules
are likely involved in the assembly of the two polyketide
chains. The four-domain PKS module of the hybrid PKS-
NRPS gene described in this study could catalyze the incor-
poration of the last two-carbon unit (C26-C27; Fig. 7) of the
first polyketide chain. This is supported by the fact that this
module lacks an enoylreductase domain, thus generating a
carbon-carbon double bond at C25 and C26, and is physically
linked to an NRPS, thus forming an amide bond between
C27 and N1. Due to the instability of the cosmids carrying
the gene cluster, we are taking the vector-rescuing approach
to locate the remaining genes, including other PKS genes.
The presence of an arginase gene in the cluster also suggests
that ornithine may be the direct substrate of NRPS. Arginase
catalyzes the conversion of arginine to urea and ornithine and
is one of the five enzymes of the urea cycle (1). This arginase
is likely an enzyme dedicated to the biosynthesis of HSAF. It is
not uncommon for “extra” copies of genes involved in primary
metabolisms to be found in the gene clusters for secondary
metabolisms (19), perhaps to provide better coordination of
gene expression and enzymatic activities within the cluster.
Thus, it is not surprising that the disruption of this gene did not
affect the production of HSAF. This result suggests that the
arginase for primary metabolism may be able to compensate
for the arginase involved in HSAF production. Alternatively,
the source of ornithine in the medium may be sufficient for
HSAF production. The ornithine moiety in HSAF, as well as
most of the tetramic acid-containing macrolactams (except ika-
rugamycin), carries a -hydroxyl group (Fig. 1), which could be
added prior to or after the incorporation of the amino acid by
NRPS (Fig. 8). The determination of either of the pathways as
illustrated in Fig. 8 needs further biochemical characterization
of the NRPS genes.
FNR is a FAD-containing protein and a member of the
electron transfer chain in energy metabolism and photosynthe-
sis. It uses the iron-sulfur-containing ferredoxin and NADP
as substrates. The structure of HSAF suggests that several
redox reactions are required during cyclization (Fig. 7). FNR is
probably involved in this process. Apparently, the role of this
FNR could be compensated for by other redox enzymes in the
organism. This is supported by the fact that the disruption of
the FNR gene in the HSAF gene cluster did not affect HSAF
production. However, current data do not exclude the possi-
bility that this FNR is not directly involved in HSAF biosyn-
thesis.
Finally, sterol desaturase catalyzes the dehydrogenation re-
action to introduce a carbon-carbon double bond into the
sterol ring system, such as sterol C5-desaturase for a double
bond at C-5–C-6 (25). Several oxidoreductions are implied in
the biosynthesis of HSAF, and the sterol desaturase may play
a role in the reactions. The disruption of this gene led to the
elimination of HSAF production and a significant increase in
the levels of two metabolites (Fig. 6). These two metabolites
were also produced by the wild-type strain at a lower level, but
their production, along with that of HSAF, was eliminated by
the disruption of the PKS-NRPS gene. These results suggest
that the metabolites may be precursors of HSAF and that the
sterol desaturase is involved in the conversion of the metabo-
lites to HSAF and its analogs.
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